Physician profile
Wei-Tzuoh Chen
NPI 1184732398
$468.65
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $79.08 · 2021: $65.37 · 2022: $170.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $81.88 | 2019-2022 | |
| Akebia Therapeutics INC | $53.64 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.66 | 2020-2022 | |
| Baxter Healthcare | $47.41 | 2019 | |
| Horizon Therapeutics Plc | $34.55 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $32.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.52 | 2022 | |
| Mallinckrodt Hospital Products INC. | $23.21 | 2021 | |
| Opko Pharmaceuticals, LLC | $23.11 | 2019-2021 | |
| Argon Medical Devices, INC. | $20.60 | 2020 | |
| Daiichi Sankyo INC. | $20.42 | 2020 | |
| Amgen INC. | $15.52 | 2019 | |
| Glaxosmithkline, LLC. | $14.87 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $12.61 | 2020 | |
| Vifor Pharma, INC. | $12.39 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei-Tzuoh Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.